GIP-Draft: {title}
- In Favour
- Against
0 voters
GIP: <to be assigned>
title: <GIP title>
author: <robert@aylab.io>
status: Draft
type: <Funding>
created: <2023-09-112>
requires (*optional): <GIP number(s)>
replaces (*optional): <GIP number(s)>
duration:<4 weeks>
funding:<$50,000>
Category
Funding - Rewards/Grants
Executive Summary:
Project objective and Value add to Gnosis: Gamifly would like to integrate with Gnosis chain including with your safe. we have significant on chain UAW (50-100k per week) and txns (1 million txns per week). We can drive mass adoption for Gnosis sustainably as we are running at a profit and scaling up means higher profitability.
Gamifly is a platform aiming at creating an inclusive and accessible community for global sports fans. We deliver year round, global and digital experiences to our community, enabling exclusive social interactions, competitive on-chain esports, digital asset ownership and trading of team memberships etc. We add value to the sports ecosystem by providing superior fan engagement, insights and targeting for sports teams and brands alike to help them unlock revenue opportunities.
Rationale
We would like to help Gnosis grow its on chain usage exponentially and as a result drive demand for Gnosis in a sustainable way.
Specs
Demo: https://youtu.be/iVc-SHObSDE
App download: https://play.google.com/store/apps/details?id=com.alabs.cricket.scifi.league
Our track record on dappradar ranking - top 27 dapp, top 8 game, top 2 sports game globally
Milestones suggested:
- Deploy on Gnosis with basic features and smart contracts (2-4 weeks) - US$15,000
- Achieve top 50 DappRadar ranking (social category, 4 weeks) - US$15,000
- Achieve top 20 DappRadar ranking (social category, 4-6 weeks) - US$20,000
Team/ Organization
Robert, Ex-BCG, Serial entrepreneur in TMT
Derek, Ex-Tencent Games, Serial entrepreneur in consumer tech
Wali, Ex-Daraz, Serial entrepreneur in sports
Rameez, Ex-BCG, Ex-Temasek, Co-founder of Circles.Life
Team Members: A group of key contributors from Dream11, MPL, Garena, and YGG.